Why do peptide programs stall in busy doctor's offices?
A peptide program usually stalls in a doctor's office for a simple reason: everyone assumes someone else is handling it. The provider is interested, a few patients start, and then the follow-up calls slip, the reorder reminders never go out, and the bottles sit in a cabinet. Three months later, the office decides peptides "didn't work for our patients," when the real problem was that nobody owned the program.
The fix is not more marketing or more products. The fix is a workflow that fits inside the day your team already runs. A primary care office, a family medicine practice, or an internal medicine group already has the pieces: scheduled visits, a medical assistant who rooms patients, a front desk that handles payment, and an EHR that stores notes. A peptide program uses all of those pieces. It needs a clear owner for each step.
This guide walks through that workflow. If you are still deciding which patients are good candidates and which protocols to start with, read Starting Patients on Peptides: A Clinical Framework for the First 90 Days first. This post picks up where that one leaves off and focuses on the operations side.
Who on the team owns each part of the program?
Every task in the program should have one owner. When two people share a task, it often gets dropped, and when the provider owns everything, the program competes with every other patient on the schedule. Most offices split the work across three roles.
| Role | What they own | Typical time per patient |
|---|---|---|
| Provider (MD, DO, NP, or PA) | Candidate review, protocol selection, informed consent, dose changes, and the decision to pause or stop | 10 to 15 minutes at the first consult, 5 minutes at follow-ups |
| Medical assistant or nurse | Intake questionnaire, baseline vitals, patient education handout, check-in calls, and side effect logging | 10 minutes at the first visit, 5 minutes per check-in |
| Front desk or practice coordinator | Scheduling, cash-pay checkout, sample pack handoff, reorder reminders, and inventory counts | 5 minutes per visit, about 30 minutes a week for inventory |
Name one person as the program lead. In most offices, that is a medical assistant or nurse who is interested in the program and organized enough to keep it moving. The program lead watches the follow-up list, flags patients who are due for a check-in, and brings questions to the provider in batches instead of interrupting the schedule all day.
How should a peptide visit fit into the existing schedule?
You do not need a separate clinic day to run a peptide program. Most offices use four visit types, and each one slots into the schedule you already keep.
- Add-on conversation during an existing visit. When a patient asks about peptides during a routine visit, the provider spends two or three minutes on fit and next steps, then the front desk books a dedicated consult. This keeps the routine visit on time.
- Dedicated consult (20 to 30 minutes). The medical assistant completes intake and vitals, the provider reviews history and goals, discusses options, and documents consent. The patient leaves with a protocol, written instructions, and a sample pack or first order.
- Short follow-up (10 to 15 minutes). At two to four weeks, the provider checks tolerance and progress. Many offices run this visit by telehealth.
- Reorder check-in (5 minutes). The medical assistant or front desk confirms the patient is tolerating the protocol, logs any side effects, and processes the reorder. If anything needs a clinical decision, the check-in goes to the provider.
Block two or three consult slots per week at first. When those slots fill consistently, add more. This approach keeps the program from crowding out your core patient panel while it grows.
Ready to add peptides to your practice?
Apply for wholesale access to pricing, protocols, and sample kits.
How do you keep inventory and reorders from becoming a second job?
Inventory feels like extra work only when the office handles it by memory. A few habits set up in the first week keep it to a short weekly task.
- Set a par level for each product. Start with enough stock to cover your active patients plus a small buffer for new starts. Adjust it after the first month based on real usage.
- Count once a week. The front desk or program lead counts stock on the same day each week and places an order when any product drops below par.
- Record lot numbers. Log the lot number for every bottle you dispense. If a patient reports a side effect, you can trace it to a specific lot and notify the manufacturer.
- Store each product as its label directs. Keep capsules and serums in a dedicated, labeled cabinet away from sample medications and patient supplies.
- Send reorder reminders before patients run out. Schedule a reminder about a week before each patient's supply ends. A text or phone call from the front desk is enough for most patients.
The reorder reminder matters more than any other habit on this list. Patients who run out and wait a few weeks to restart often drop off, while patients who get a reminder usually continue.
What should the documentation look like?
Document a peptide protocol the same way you document any other treatment plan. A consistent note template saves time and protects the practice if a question comes up later. Each patient chart should include:
- The intake questionnaire and baseline vitals or labs
- The signed informed consent form, including the regulatory status of each product
- The protocol: product, dose, schedule, and planned duration
- The lot number of each product dispensed
- Notes from every follow-up and check-in, including any side effects and how the office responded
Build these items into an EHR template so the medical assistant can complete most of the note before the provider sees the patient. For the clinical side of follow-up, including what to track and when to pause a protocol, see Peptide Side Effects and Safety Monitoring.
How do you keep cash-pay services separate from insurance billing?
Peptide programs run as cash-pay services, and doctor's offices that also bill insurance need a clean line between the two. Patients should never be confused about what their insurance covers and what they pay for directly.
Most offices handle this with three pieces. First, keep a separate fee schedule for the peptide program. Second, write a short financial policy that explains the program is self-pay and not billed to insurance. Third, have each patient sign an acknowledgment of that policy at the first consult and keep it in the chart. Check out program payments separately from copays so your reports stay clean.
Billing rules differ by payer and by state, and they get more detailed if you see Medicare patients. Review your setup with your billing or compliance advisor before you launch.
Which three numbers show the workflow is working?
You can tell whether the workflow is working by tracking three numbers each month. You do not need a dashboard for this. A shared spreadsheet that the program lead updates is enough.
- Consult-to-start rate. The share of patients who start a protocol after a dedicated consult. A low rate usually means the consult needs clearer next steps or a sample pack.
- 30-day reorder rate. The share of patients who reorder after their first supply. A low rate usually points to missed reminders or a tolerance issue the office did not catch.
- Provider minutes per patient. The average provider time per active patient each month. If this number climbs, move more of the routine work to the medical assistant and front desk.
Review these numbers in a 15-minute monthly meeting with the provider and the program lead. Small adjustments made each month keep the program steady without a major overhaul.
How does AgeREcode support the office side?
PB Distributors, an authorized AgeREcode dealer, gives approved practices tools built for the workflow in this guide. The Clinical Operator's Manual covers program setup, staff roles, and patient flow. The Peptide Protocol Portal at PeptideProtocolPortal.com includes more than 200 protocols and a training video library your medical assistants and front desk can use during onboarding. Approved practices also get compliance templates, sample kits, and one-week trial protocols that make the dedicated consult easier to close.
Because the AgeREcode line uses enteric-coated oral capsules and topical serums, the office does not need injection supplies, sharps disposal, or injection training for these products. That keeps the visit flow short. For more on how the delivery format works, read Oral Peptides vs. Injections.
Frequently Asked Questions
Do we need a separate clinic day for peptide patients?
No. Most offices run a peptide program inside the existing schedule with two or three blocked consult slots per week, short follow-ups, and reorder check-ins handled by staff. Add more consult slots as demand grows.
Who should be the program lead in a doctor's office?
A medical assistant or nurse is usually the best choice. The program lead tracks the follow-up list, runs check-ins, and brings clinical questions to the provider in batches. The provider still makes every protocol decision.
How much provider time does a peptide program take?
The first consult takes about 10 to 15 minutes of provider time, and each follow-up takes about 5. Staff handle intake, education, check-ins, and reorders, which keeps provider time low as the program grows.
How do we handle reorders without running out of stock?
Set a par level for each product, count inventory once a week, and send each patient a reorder reminder about a week before their supply runs out. Record lot numbers for every bottle you dispense.
Can a doctor's office that bills insurance offer a cash-pay peptide program?
Many do. Keep a separate fee schedule, a written self-pay financial policy, and a signed patient acknowledgment in each chart. Review the setup with your billing or compliance advisor, especially if you see Medicare patients.
This article is general operational education for licensed providers. It is not legal, billing, or medical advice. Review your program with counsel and a billing advisor familiar with your state's rules. Prescribing and monitoring decisions rest with the licensed provider.




